PROCEPT BioRobotics Corporation Common Stock (PRCT) Stock Price

PRCTStock
$21.6048.46%52W
Market Cap$1.23B
P/E
PEG Ratio
Div yield
Beta0.93

PRCT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-34.59%
Price vs S&P 500 (4W)14.48%
VGM Score53.66

PRCT Earnings Surprise History

Q2 25-0.35est. -0.41
Q3 25-0.38est. -0.42
Q4 25-0.53est. -0.32
Q1 26-0.56est. -0.56
Q2 26-0.47est. -0.45

PRCT Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.90
3.90
3.82
3.71

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PRCTPROCEPT BioRobotics Corporation Common Stock
CAD$21.60
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About PROCEPT BioRobotics Corporation Common Stock

PROCEPT BioRobotics develops, manufactures, and sells image-guided robotic surgical systems for minimally invasive urologic procedures. The company's AquaBeam and HYDROS platforms primarily address the benign prostatic hyperplasia market, with revenue concentrated in the United States and expanding international operations.